BioSpace News Archive

Mezzion Pharma Co., Ltd. (Mezzion Pharma) met with the FDA Division of Cardiology and Nephrology (DCN) on Friday, May 27th to discuss with the FDA the path forward for the regulatory approval of udenafil for the treatment of single ventricle heart disease (SVHD) in children with Fontan physiology.

Medtronic plc, a global leader in healthcare technology, announced it will participate in the 43rd annual Goldman Sachs global healthcare conference on Tuesday, June 14, 2022.

According to Vision Research Reports, the liver cancer diagnostics market size is expected to be worth around US$ 20.4 billion by 2030 from valued at US$ 10.7 billion in 2020 and is anticipated to grow at a CAGR of 8.5% from 2021 to 2030.

The global veterinary endoscopes market size is expected to be worth around US$ 415.2 million by 2030 and is anticipated to grow at a CAGR of 7.6% over forecast period 2021 to 2030.

Foghorn® Therapeutics Inc. announced management’s participation in the following investor conferences.

LAVA Therapeutics N.V. announced the Annual General Meeting of Shareholders will take place on Wednesday, June 15, 2022, at 7:30 a.m. CEST, at Beethovenstraat 400, 1082 PR, Amsterdam, the Netherlands.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced upcoming abstract presentations at three key medical conferences taking place in June, which highlight TAVNEOS® (avacopan).

Nevro Corp. (NYSE: NVRO), today announced that data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT), the largest RCT to evaluate spinal cord stimulation (SCS) to treat PDN, will be presented at the American Diabetes Association (ADA) 82nd Scientific Sessions to be held June 3-7, 2022 in New Orleans, LA.

Concert Pharmaceuticals, Inc. announced that it intends to offer and sell 10,000,000 shares of its common stock in an underwritten registered public offering.

Arcus Biosciences (NYSE:RCUS), announced that its management team will participate in a fireside chat at the upcoming Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California.